Trials / Unknown
UnknownNCT01133509
A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study
A Model for the Implementation of the Cervical Cancer Screening and HPV Vaccination in the Emergency Department: a Pilot Study.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Eastern Virginia Medical School · Academic / Other
- Sex
- Female
- Age
- 18 Years – 26 Years
- Healthy volunteers
- Accepted
Summary
In this pilot study, we intend to demonstrate that a great portion of women at high risk (inadequate screening, HPV 16/18 and/or cytology) are presenting to the ED, cytology/ HPV testing via ThinPrep®Pap testTM and surveillance. We intend to provide improved access to healthcare and monitoring through administration of vaccine to eligible patients and 1 year follow up for patients involved in this study. Females meeting inclusion/exclusion criteria participating in the study (n=100) that have not had a cytology test in 2 or more years will be offered the Thin Prep® cytology test. This study will allow surveillance of disease through cytology and HPV DNA testing via collection of data using Thin Prep® cytology with reflex HPV DNA testing according to established guidelines as described below. Provide improved access to healthcare and monitoring through administration of vaccine for eligible females as established by guidelines. Patients will receive first vaccine in the ED and will have arranged follow up for administration of the 2 month and 6 month series of the HPV vaccination. Through data collection, we intend to determine if there is a need for vaccination and determine if patients are likely to follow up..
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gardasil | 0.5ml IM for three doses, Second and third dose to be given at 2 months and 6 months |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2012-09-01
- Completion
- 2012-10-01
- First posted
- 2010-05-31
- Last updated
- 2012-08-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01133509. Inclusion in this directory is not an endorsement.